These findings might suggest dysregulation between IL-1 and IL-10 in cholesteatoma, and therefore, more favorable conditions for inflammatory processes in the cholesteatoma perimatrix, which may likely cause bone destruction. This evidence concerns the gene IL10 and cholesteatoma.